Citigroup’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.95M | Sell |
|
|||||
|
2025
Q1 | $19M | Buy |
|
|||||
|
2024
Q4 | $14.4M | Buy |
|
|||||
|
2024
Q3 | $14.6M | Buy |
|
|||||
|
2024
Q2 | $14M | Sell |
|
|||||
|
2024
Q1 | $19.4M | Buy |
|
|||||
|
2023
Q4 | $18.4M | Sell |
|
|||||
|
2023
Q3 | $18.5M | Sell |
|
|||||
|
2023
Q2 | $18.8M | Sell |
|
|||||
|
2023
Q1 | $26.2M | Buy |
|
|||||
|
2022
Q4 | $18.5M | Sell |
|
|||||
|
2022
Q3 | $18M | Buy |
|
|||||
|
2022
Q2 | $14.9M | Buy |
|
|||||
|
2022
Q1 | $9.34M | Sell |
|
|||||
|
2021
Q4 | $27.9M | Buy |
|
|||||
|
2021
Q3 | $18.5M | Sell |
|
|||||
|
2021
Q2 | $21.2M | Sell |
|
|||||
|
2021
Q1 | $19.7M | Buy |
|
|||||
|
2020
Q4 | $20.3M | Sell |
|
|||||
|
2020
Q3 | $19.8M | Sell |
|
|||||
|
2020
Q2 | $32.7M | Buy |
|
|||||
|
2020
Q1 | $20.2M | Buy |
|
|||||
|
2019
Q4 | $20.1M | Sell |
|
|||||
|
2019
Q3 | $16.1M | Buy |
|
|||||
|
2019
Q2 | $14.7M | Buy |
|
|||||
|
2019
Q1 | $13.3M | Buy |
|
|||||
|
2018
Q4 | $12.3M | Buy |
|
|||||
|
2018
Q3 | $12.6M | Buy |
|
|||||
|
2018
Q2 | $11.8M | Buy |
|
|||||
|
2018
Q1 | $2.86M | Sell |
|
|||||
|
2017
Q4 | $4.06M | Buy |
|
|||||
|
2017
Q3 | $3.05M | Sell |
|
|||||
|
2017
Q2 | $8.4M | Buy |
|
|||||
|
2017
Q1 | $5.63M | Sell |
|
|||||
|
2016
Q4 | $14.9M | Buy |
|
|||||
|
2016
Q3 | $4.92M | Buy |
|
|||||
|
2016
Q2 | $3.64M | Sell |
|
|||||
|
2016
Q1 | $5.67M | Sell |
|
|||||
|
2015
Q4 | $7.4M | Sell |
|
|||||
|
2015
Q3 | $13.3M | Sell |
|
|||||
|
2015
Q2 | $18.1M | Buy |
|
|||||
|
2015
Q1 | $10.2M | Buy |
|
|||||
|
2014
Q4 | $4.57M | Sell |
|
|||||
|
2014
Q3 | $7.94M | Buy |
|
|||||
|
2014
Q2 | $4.88M | Buy |
|
|||||
|
2014
Q1 | $2.13M | Buy |
|
|||||
|
2013
Q4 | $1.77M | Sell |
|
|||||
|
2013
Q3 | $3.3M | Buy |
|
|||||
|
2013
Q2 | $1.53M | Buy |
|